Real-world outcome of dostarlimab in dMMR/MSI-H advanced/recurrent endometrial cancer: Updated results from Korean expanded access program
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
Real-world outcome of dostarlimab in dMMR/MSI-H advanced/recurrent endometrial cancer: Updated results from Korean expanded access program
저자
Kim, M. K.Kim, K.Lee, Y-YNam, E. J.Lim, M. C.Kim, K. H.Song, J. Y.Kim, H. S.Kwon, Y-SBae, J.Kim, M. K.Bae, M. J.
DOI
10.1016/j.annonc.2024.10.418
발행일
2024-12
유형
Meeting Abstract
저널명
Annals of Oncology
35
페이지
S1552 ~ S1552